Nyxoah Prices $95M Offering, Massively Diluting Shareholders Amid Going Concern Warnings
NYXH is trading near its 52-week low of $1.44 (9.6% above the low) on elevated volume (9.2× avg).
Summary
Nyxoah has priced a $95 million public offering of 55.2 million ordinary shares at $1.72 each. This follows yesterday's announcement of a proposed offering and multiple recent SEC filings that raised substantial doubt about the company's ability to continue as a going concern and noted a very short cash runway. The offering size significantly exceeds Nyxoah's current market capitalization, implying massive dilution for existing shareholders. While this capital infusion is critical for the company's survival and expansion plans, the terms are highly unfavorable for current equity holders. The offering is expected to close around June 9, 2026.
At the time of this announcement, NYXH was trading at $1.58 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $70.6M. The 52-week trading range was $1.44 to $8.59. This news item was assessed with negative market sentiment and an importance score of 9 out of 10. Source: GlobeNewswire.